These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 6549160)
1. Effect of allopurinol treatment in premature infants with idiopathic respiratory distress syndrome. Boda D; Németh I; Hencz P; Dénes K Dev Pharmacol Ther; 1984; 7(6):357-67. PubMed ID: 6549160 [TBL] [Abstract][Full Text] [Related]
2. Purine metabolism and inhibition of xanthine oxidase in severely hypoxic neonates going onto extracorporeal membrane oxygenation. Marro PJ; Baumgart S; Delivoria-Papadopoulos M; Zirin S; Corcoran L; McGaurn SP; Davis LE; Clancy RR Pediatr Res; 1997 Apr; 41(4 Pt 1):513-20. PubMed ID: 9098853 [TBL] [Abstract][Full Text] [Related]
3. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats. Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381 [TBL] [Abstract][Full Text] [Related]
4. Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees. Komoriya K; Osada Y; Hasegawa M; Horiuchi H; Kondo S; Couch RC; Griffin TB Eur J Pharmacol; 1993 Dec; 250(3):455-60. PubMed ID: 8112406 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency. Torres RJ; Prior C; Puig JG Metabolism; 2007 Sep; 56(9):1179-86. PubMed ID: 17697859 [TBL] [Abstract][Full Text] [Related]
6. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Siu YP; Leung KT; Tong MK; Kwan TH Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385 [TBL] [Abstract][Full Text] [Related]
7. Allopurinol-induced effects in premature baboons with respiratory distress syndrome. Jenkinson SG; Roberts RJ; DeLemos RA; Lawrence RA; Coalson JJ; King RJ; Null DM; Gerstmann DR J Appl Physiol (1985); 1991 Mar; 70(3):1160-7. PubMed ID: 2032982 [TBL] [Abstract][Full Text] [Related]
8. Effect of allopurinol and benzbromarone on the concentration of uridine in plasma. Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K Metabolism; 1997 Dec; 46(12):1473-6. PubMed ID: 9439546 [TBL] [Abstract][Full Text] [Related]
9. Allopurinol or oxypurinol in heart failure therapy - a promising new development or end of story? Reyes AJ; Leary WP Cardiovasc Drugs Ther; 2005 Oct; 19(5):311-3. PubMed ID: 16382292 [TBL] [Abstract][Full Text] [Related]
10. Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution's, pharmacokinetic and pilot prospective study. Takai M; Yamauchi T; Ookura M; Matsuda Y; Tai K; Kishi S; Yoshida A; Iwasaki H; Nakamura T; Ueda T Anticancer Res; 2014 Dec; 34(12):7287-96. PubMed ID: 25503162 [TBL] [Abstract][Full Text] [Related]
11. Influence of urate-lowering therapies on renal handling of uric acid. Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449 [TBL] [Abstract][Full Text] [Related]
12. Role of hyperuricaemia in critically ill patients especially newborns. Boda D Acta Paediatr Hung; 1984; 25(1-2):23-32. PubMed ID: 6383436 [TBL] [Abstract][Full Text] [Related]
13. Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats. Yamamoto Y; Ogino K; Igawa G; Matsuura T; Kaetsu Y; Sugihara S; Matsubara K; Miake J; Hamada T; Yoshida A; Igawa O; Yamamoto T; Shigemasa C; Hisatome I Hypertens Res; 2006 Nov; 29(11):915-21. PubMed ID: 17345792 [TBL] [Abstract][Full Text] [Related]
14. Allopurinol, an inhibitor of xanthine oxidase, reduces uric acid levels and modifies the signs associated with copper deficiency in rats fed fructose. Fields M; Lewis CG; Lure MD Free Radic Biol Med; 1996; 20(4):595-600. PubMed ID: 8904301 [TBL] [Abstract][Full Text] [Related]
15. Effect of furosemide on renal excretion of oxypurinol and purine bases. Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436 [TBL] [Abstract][Full Text] [Related]
16. Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities. Fuchs P; Haefeli WE; Ledermann HR; Wenk M Eur J Clin Pharmacol; 1999 Jan; 54(11):869-76. PubMed ID: 10027663 [TBL] [Abstract][Full Text] [Related]
17. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi. Emmerson BT Australas Ann Med; 1967 Aug; 16(3):205-14. PubMed ID: 6056609 [No Abstract] [Full Text] [Related]
18. Allopurinol as a therapeutic option in cardiovascular disease. Okafor ON; Farrington K; Gorog DA Pharmacol Ther; 2017 Apr; 172():139-150. PubMed ID: 27916655 [TBL] [Abstract][Full Text] [Related]
19. Prevention of recurrent uric acid and calcium oxalate stones by administration of the xanthine oxidase inhibitors Milurit 100 and Milurit 300. Schneider HJ; Brundig P; Balogh A; Traeger A; Stein G; Fünfstück R Int Urol Nephrol; 1983; 15(2):121-9. PubMed ID: 6688800 [TBL] [Abstract][Full Text] [Related]
20. Allopurinol: Old Drug, New Indication in Neonates? Annink KV; Franz AR; Derks JB; Rudiger M; Bel FV; Benders MJNL Curr Pharm Des; 2017; 23(38):5935-5942. PubMed ID: 28925896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]